Xilio Therapeutics, Inc. (XLO)
NASDAQ·Healthcare·Biotechnology
$7.88
-3.67%
Mkt Cap $28.36M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 23, 2026 | $10.90M | $13.69M | +25.60% | -$1.68 | -$0.85 | +49.40% | — | — |
| Q4 2025 Nov 13, 2025 | $18.64M | $19.07M | +2.31% | -$0.45 | -$0.03 | +93.28% | — | — |
| Q3 2025 Aug 14, 2025 | $18.64M | $8.08M | -56.62% | -$1.10 | -$0.16 | +85.50% | — | — |
| Q2 2025 May 8, 2025 | $23.20M | $2.93M | -87.37% | -$2.70 | -$0.18 | +93.33% | — | — |
| Q1 2025 Mar 11, 2025 | $23.20M | $1.72M | -92.57% | -$3.03 | -$0.20 | +93.41% | — | — |
| Q4 2024 Nov 7, 2024 | $3.30M | $2.26M | -31.42% | -$0.25 | -$0.22 | +12.00% | — | — |
| Q3 2024 Aug 8, 2024 | $30.00M | $2.36M | -92.14% | -$0.23 | -$0.24 | -4.35% | — | — |
| Q2 2024 May 14, 2024 | $30.00M | — | — | -$0.11 | -$0.62 | -463.64% | — | — |
| Q2 2024 Apr 1, 2024 | $30.00M | — | — | -$0.64 | -$0.64 | +0.00% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.81 | -$0.61 | +24.69% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.87 | -$0.70 | +19.54% | — | — |
| Q2 2023 May 9, 2023 | — | — | — | -$0.89 | -$0.83 | +6.74% | — | — |
| Q1 2023 Mar 2, 2023 | — | — | — | -$0.78 | -$0.82 | -5.13% | — | — |
| Q4 2022 Nov 9, 2022 | — | — | — | -$0.88 | -$0.72 | +18.18% | — | — |
| Q3 2022 Aug 9, 2022 | — | — | — | -$0.78 | -$0.90 | -15.38% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$0.93 | -$0.78 | +16.13% | — | — |
| Q1 2022 Mar 1, 2022 | — | — | — | -$1.17 | -$0.98 | +16.24% | — | — |
| Q4 2021 Dec 2, 2021 | — | — | — | -$1.60 | -$21.27 | -1229.37% | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.87 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.63 | — | — | — |